1,039 findings · Mixed · published 2022+
- MixedModerate
Sarcopenia is associated with significantly reduced health-related quality of life (HRQoL) compared to non-sarcopenic individuals, with a large effect size observed when using disease-specific assessment tools.
If you are an older adult experiencing muscle loss, do not dismiss it as inevitable aging. This condition, known as sarcopenia, is linked to a significant drop in your quality of life and independence. Seek a diagnosis using standard criteria (like EWGSOP2) to ensure you receive appropriate interventions, as generic assessments might miss the severity of your condition.
Supports 2023 - MixedModerate
Inositol supplementation shows the most promising findings for improving metabolic profiles and reducing hyperandrogenism in PCOS, whereas other supplements, herbal medicines, acupuncture, and yoga have inconsistent evidence.
If considering supplements, inositol has the most promising evidence for improving metabolic health and hormone levels in PCOS. However, evidence for other supplements, herbal medicines, acupuncture, and yoga is inconsistent. Do not rely on these as primary treatments; consult a healthcare provider before starting any supplement.
Supports 2023 - MixedModerate
SARS-CoV-2 infection is associated with a significant reduction in exercise capacity (peak VO2), particularly in individuals with Long COVID symptoms, with mechanisms including deconditioning, dysfunctional breathing, chronotropic incompetence, and impaired peripheral oxygen extraction.
If you have Long COVID and feel exhausted by activity, standard 'push through it' advice may be harmful. Get a Cardiopulmonary Exercise Test (CPET) to identify if your limitation is due to deconditioning, heart rate issues (chronotropic incompetence), or breathing problems. Treatment should be tailored to the specific mechanism found, rather than generic exercise.
Supports 2022 - MixedModerate
Increasing adherence to plant-based dietary patterns over time is associated with a reduced risk of type 2 diabetes and a marginally lower risk of mortality.
Improving your diet to include more plant-based foods over time can lower your risk of type 2 diabetes and may slightly reduce your risk of death.
Supports 2023 - MixedModerate
Probiotics (specifically Lactobacillus and Bifidobacterium strains) improve gastrointestinal health by modulating the immune system, enhancing epithelial barriers, and suppressing pathogen adhesion.
To support gut health, consider incorporating probiotic-rich foods or supplements containing Lactobacillus or Bifidobacterium strains. These microbes help maintain the gut barrier and support immune function. If you are immunocompromised, consult a doctor first to ensure the specific strain is safe for you.
Supports 2025New - MixedModerate
Facial volume loss from GLP-1 agonists can be effectively treated with dermal fillers, skin tightening techniques, and surgical interventions.
If your face looks hollow after weight loss, consult a plastic surgeon. Treatments like fillers, lasers, or facelifts can restore volume and tighten skin. Be prepared for the costs and recovery time.
Supports 2023 - MixedModerate
Branched-chain amino acid (BCAA) dysregulation directly causes pro-arrhythmic effects, including action potential prolongation and calcium dysregulation, independent of structural cardiac changes.
If you have diabetes or obesity, your risk of dangerous heart rhythms may be linked to how your body processes specific amino acids (leucine, isoleucine, valine) found in protein. While you don't necessarily need to eliminate protein, focusing on dietary patterns that improve metabolic health, such as the Mediterranean diet, may help lower BCAA levels and reduce arrhythmia risk. Consult your doctor about your specific metabolic profile.
Supports 2022 - MixedModerate
Repeated application of cooling does not affect endurance training adaptations following 4–6 week training interventions.
If you are training for endurance, you can use cold water immersion without worrying about it hurting your long-term aerobic gains. It won't help them either, so use it based on comfort or early recovery needs, not for chronic adaptation.
Refutes 2022 - MixedModerate
Non-surgical weight management programs (WMPs) for adults with severe obesity (BMI ≥ 35 kg/m2) lack a clear consensus on cost-effectiveness, largely due to short-term study durations and heterogeneous definitions of usual care.
For individuals with severe obesity (BMI ≥ 35), non-surgical weight management programs exist but their cost-effectiveness is not clearly established. Most studies are short-term and do not capture long-term health outcomes. It is important to consult with healthcare providers to understand the potential benefits and costs of various non-surgical options, including lifestyle changes, VLCDs, and pharmacotherapy, as the evidence is heterogeneous.
Qualifies 2022 - MixedModerate
Obesogenic food environments disproportionately increase obesity risk for women compared to men due to biological factors (hormonal modulation of taste/storage), gendered marketing targeting women, and structural burdens (unpaid labor/food security) that limit healthy food access.
Recognize that obesity is not just a personal failure but a result of an environment designed to promote weight gain, which affects women differently due to biological and social factors. Focus on structural changes (policy, food environment) rather than just individual willpower. For women, be aware that marketing and household responsibilities may create unique barriers to healthy eating that require specific, gender-responsive solutions.
Supports 2024 - MixedModerate
General obesity does not significantly increase the risk of incident cardiovascular disease (CVD) events in individuals with type 2 diabetes, although it does increase mortality risk.
For people with diabetes, managing weight is less about preventing heart attacks and more about preventing death from any cause. While obesity doesn't significantly increase CVD risk in diabetics, it does increase mortality risk, so weight management remains important.
Qualifies 2024 - MixedModerate
A healthy vegan diet increases basophil levels in the blood, whereas a healthy omnivorous diet decreases them, indicating diet-specific immune system modulation.
Switching to a healthy vegan diet may alter your immune profile by increasing basophil levels, a type of white blood cell. While this is a specific change, it highlights that plant-based diets actively modulate the immune system rather than just suppressing it.
Supports 2023 - MixedModerate
A healthy vegan diet increases methylation at the ABCG1 locus (potentially elevating Type 2 Diabetes risk) while simultaneously increasing methylation at the PHOSPHO1 locus (potentially reducing Type 2 Diabetes risk), creating a complex and opposing effect on T2D biomarkers.
A healthy vegan diet has complex effects on Type 2 Diabetes biomarkers, increasing methylation at one locus (potentially raising risk) and another (potentially lowering risk). This suggests that the net effect on T2D risk is not straightforward and requires further investigation.
Qualifies 2023 - MixedModerate
Resistance training does not significantly improve appendicular skeletal muscle mass (ASM) or appendicular skeletal muscle mass index (ASMI) in older adults with sarcopenia.
Do not expect resistance training to significantly increase your muscle mass or muscle mass index if you have sarcopenia. The benefits you feel (strength, balance) are likely due to your nervous system working better, not your muscles getting bigger. This is still a positive outcome for function, even if the scale or tape measure doesn't change much.
Refutes 2025New - MixedModerate
Spirulina supplementation does not significantly reduce waist circumference in the general adult population, though it may benefit obese individuals over 40.
Do not expect Spirulina to significantly reduce waist circumference for the general population. However, if you are obese and over 40, taking ≥2g/day may help. Focus on its proven benefits for overall weight and body fat reduction instead.
Qualifies 2025New - MixedModerate
Public health strategies targeting the obesogenic environment (e.g., SSB taxes, zoning, produce prescriptions) are necessary to support individual weight management efforts, as individual lifestyle advice is undermined by environmental factors.
Individual willpower is not enough in an environment designed to promote obesity. Support public health policies like sugar taxes, zoning for healthy food access, and produce prescription programs. These environmental changes make healthy choices easier and more affordable.
Qualifies 2025New - MixedModerate
Long-term intermittent fasting (IF) protocols, particularly time-restricted eating (TRE) with short windows (e.g., 8 hours), are associated with increased cardiovascular disease (CVD) mortality and adverse cardiac structural changes, primarily mediated by lean mass loss, circadian misalignment, and reward-based poor dietary choices.
If you practice intermittent fasting, be aware that long-term use (especially with very short eating windows like 8 hours) may increase your risk of heart disease and mortality, particularly if you have existing heart conditions or genetic risks. The benefits seen in short-term studies (less than 12 weeks) do not necessarily translate to long-term health. Focus on preserving muscle mass, eating nutrient-dense foods, and consider combining fasting with exercise or switching to a Mediterranean diet for better long-term cardiovascular outcomes.
Refutes 2025New - MixedModerate
Endoscopic Bariatric Procedures (EBP), including intragastric balloon (IGB), aspiration therapy (AT), and primary obesity surgery endoluminal (POSE), are generally less effective than newer OMMs (semaglutide, tirzepatide) and have limited long-term data.
Endoscopic procedures (IGB, AT, POSE, ESG) offer moderate weight loss (3.8-12.8% TBWL) in the short term but are generally less effective than newer medications (semaglutide, tirzepatide) and lack long-term efficacy data. They may be considered for patients who are not candidates for surgery or high-dose medications, but they are not the most effective option for significant, sustained weight loss.
Refutes 2026New - MixedModerate
Manipulations of resistance training variables (such as volume, intensity, or frequency) have a negligible impact on muscle fiber hypertrophy compared to intrinsic biological factors.
Stop obsessing over perfecting your set and rep schemes. Your genetic and biological response to training is the main driver of muscle growth, not whether you do 8 reps or 12. Focus on consistent, hard training and recovery rather than constantly changing variables.
Refutes 2022 - MixedModerate
Adipose-derived mesenchymal stem cell (ADMSC) therapy reduces body weight and improves metabolic complications (diabetes, NAFLD) in animal models, though clinical efficacy remains controversial due to low cell survival rates.
ADMSC therapy shows promise in reducing weight and improving metabolic health in animal studies, but it is not yet a standard or proven treatment for humans. Clinical efficacy is controversial, and cell survival after transplantation is low. Patients should not expect this to be a current standard of care.
Qualifies 2023 - MixedModerate
Geroscience aims to compress the period of morbidity by targeting the fundamental biological mechanisms of aging, rather than treating individual age-related diseases in isolation.
This paper outlines a research strategy, not a direct lifestyle intervention. However, the implication for an individual is that healthspan (the period of life spent in good health) is a distinct and measurable goal from lifespan. Supporting geroscience research involves advocating for and participating in studies that target fundamental aging processes (like cellular senescence or metabolic regulation) rather than just managing symptoms of single diseases as they appear.
Supports 2025New - MixedModerate
Oral superabsorbent hydrogel (OSH) administration prevents diet-induced obesity and metabolic syndrome in mice by preserving gut barrier integrity and expanding Akkermansia muciniphila.
This research suggests that a specific type of hydrogel, when taken with meals, may help prevent weight gain and metabolic issues by protecting the gut lining and encouraging the growth of beneficial bacteria (A. muciniphila). While promising in mice, this is not yet a proven human therapy. Focus on proven methods like diet and exercise for now.
Supports 2023 - MixedModerate
OSH administration expands Akkermansia muciniphila abundance in the gut microbiota, which is associated with improved metabolic health.
This study shows that OSH can increase the levels of Akkermansia muciniphila, a bacterium linked to better metabolic health, in mice. This is a promising area of research, but it is not yet a proven strategy for humans.
Supports 2023 - MixedModerate
Peak week strategies in non-drug-free bodybuilders, including supraphysiological anabolic steroid use, diuretics, and severe caloric/water restriction, fail to prevent significant losses in lean mass markers and resting metabolic rate.
If you are preparing for a physique competition using performance-enhancing drugs and extreme peak week strategies, be aware that these methods often fail to preserve lean muscle mass and metabolic rate. The combination of high-volume cardio, severe caloric restriction, and polypharmacy can lead to significant muscle loss despite the use of steroids. Individualize your protocol rather than copying a single coach's 'one-size-fits-all' approach, and prioritize muscle preservation over extreme dehydration tactics.
Refutes 2023